These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 9316639)
1. Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis. Kundu N; Fulton AM Cell Immunol; 1997 Aug; 180(1):55-61. PubMed ID: 9316639 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 reduces natural killer sensitivity and downregulates MHC class I expression on H-ras-transformed cells. Tsuruma T; Yagihashi A; Torigoe T; Sato N; Kikuchi K; Watanabe N; Hirata K Cell Immunol; 1998 Mar; 184(2):121-8. PubMed ID: 9630838 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 reduces natural killer (NK) sensitivity of tumor cells by downregulating NK target structure expression. Tsuruma T; Yagihashi A; Hirata K; Torigoe T; Araya J; Watanabe N; Sato N Cell Immunol; 1999 Dec; 198(2):103-10. PubMed ID: 10648124 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity. Hafner M; Falk W; Echtenacher B; Männel DN Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121 [TBL] [Abstract][Full Text] [Related]
5. Natural killer cells play a role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro. Kijima M; Saio M; Oyang GF; Suwa T; Miyauchi R; Kojima Y; Imai H; Nakagawa J; Nonaka K; Umemura N; Nishimura T; Takami T Int J Oncol; 2005 Mar; 26(3):679-84. PubMed ID: 15703823 [TBL] [Abstract][Full Text] [Related]
6. Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants. Ljunggren HG; Sturmhöfel K; Wolpert E; Hämmerling GJ; Kärre K J Immunol; 1990 Jul; 145(1):380-6. PubMed ID: 2113557 [TBL] [Abstract][Full Text] [Related]
7. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Ma D; Luyten GP; Luider TM; Niederkorn JY Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):435-41. PubMed ID: 7843912 [TBL] [Abstract][Full Text] [Related]
8. IFN-gamma production and cytotoxicity of IL-2-activated murine NK cells are differentially regulated by MHC class I molecules. Kubota A; Lian RH; Lohwasser S; Salcedo M; Takei F J Immunol; 1999 Dec; 163(12):6488-93. PubMed ID: 10586040 [TBL] [Abstract][Full Text] [Related]
9. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells. Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295 [TBL] [Abstract][Full Text] [Related]
10. H-2Kb antigen expression has no effect on natural killer susceptibility and tumorigenicity of a murine hepatoma. Nishimura MI; Stroynowski I; Hood L; Ostrand-Rosenberg S J Immunol; 1988 Dec; 141(12):4403-9. PubMed ID: 3264312 [TBL] [Abstract][Full Text] [Related]
11. IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression. Salazar-Onfray F; Petersson M; Franksson L; Matsuda M; Blankenstein T; Kärre K; Kiessling R J Immunol; 1995 Jun; 154(12):6291-8. PubMed ID: 7759867 [TBL] [Abstract][Full Text] [Related]
12. Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene. Gorelik E; Jay G; Kwiatkowski B; Herberman RB J Immunol; 1990 Sep; 145(5):1621-32. PubMed ID: 2384672 [TBL] [Abstract][Full Text] [Related]
13. High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells. Versteeg R; Peltenburg LT; Plomp AC; Schrier PI J Immunol; 1989 Dec; 143(12):4331-7. PubMed ID: 2512356 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors. Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647 [TBL] [Abstract][Full Text] [Related]
15. Negative regulation of rat natural killer cell activity by major histocompatibility complex class I recognition. Kraus E; Lambracht D; Wonigeit K; Hünig T Eur J Immunol; 1996 Nov; 26(11):2582-6. PubMed ID: 8921942 [TBL] [Abstract][Full Text] [Related]
17. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro. Mammolenti M; Gajavelli S; Tsoulfas P; Levy R Stem Cells; 2004; 22(6):1101-10. PubMed ID: 15536199 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2. Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D. Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507 [TBL] [Abstract][Full Text] [Related]
20. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL. Bakker AB; Phillips JH; Figdor CG; Lanier LL J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]